Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX
Showing element 382 to 431 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
baculoviral iap repeat-containing protein 5 (apoptosis inhibitor survivin) (apoptosis inhibitor 4). [source:swissprot;acc:o15392]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2024\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6323.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5976.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-1 (bcl-2 binding athanogene- 1) (bag-1) (glucocorticoid receptor-associated protein rap46). [source:swissprot;acc:q99933]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1322\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-2. [source:swissprot;acc:o95816]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2471\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8004\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7765.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03074\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-3 (bcl-2 binding athanogene- 3) (bag-3) (bcl-2-binding protein bis) (docking protein cair-1). [source:swissprot;acc:o95817]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5233.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4522.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15708\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5480.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5254.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
394\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5222.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4490.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
969\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8569.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.34\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
971\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8569.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
970\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8570.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.45\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2129\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5616.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5328.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
barrier-to-autointegration factor (breakpoint cluster region protein 1). [source:swissprot;acc:o75531]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2804\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
908\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10770.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11848.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10014\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
basic proline-rich peptide p-e (ib-9). [source:swissprot;acc:p02811]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1920\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6652.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6262.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0623\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bax inhibitor-1 (bi-1) (testis enhanced gene transcript). [source:swissprot;acc:p55061]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2950\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
bcl-6 interacting corepressor isoform 1. [source:refseq;acc:nm\_017745]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2776\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beclin 1 (coiled-coil myosin-like bcl2-interacting protein) (protein gt197). [source:swissprot;acc:q14457]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2650\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9234.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9150.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
20483.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17396.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17745\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta adducin (erythrocyte adducin beta subunit). [source:swissprot;acc:p35612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1368\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6248.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5793.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (skeletal muscle enolase) (mse) (enolase 3). [source:swissprot;acc:p13929]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
944\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-1,4 mannosyltransferase. [source:refseq;acc:nm\_019109]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7089.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9275.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30826\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-1-syntrophin (59 kda dystrophin-associated protein a1, basic component 1) (dapa1b) (tax interaction protein 43) (tip-43) (syntrophin 2) (bsyn2). [source:swissprot;acc:q13884]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1764\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6218.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5829.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06667\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
beta-2-syntrophin (59 kda dystrophin-associated protein a1, basic component 2) (syntrophin 3) (snt3) (syntrophin-like) (sntl). [source:swissprot;acc:q13425]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1765\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
68\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
67\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-carotene 15, 15'-dioxygenase; beta-carotene 15,15'-monooxygenase. [source:refseq;acc:nm\_017429]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1673\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6193.02\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0694\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1672\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1029\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6166.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5635.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-centractin (actin-related protein 1b) (arp1b). [source:swissprot;acc:p42025]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1152\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08838\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-soluble nsf attachment protein (snap-beta) (n-ethylmaleimide- sensitive factor attachment protein, beta). [source:swissprot;acc:q9h115]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2718\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
beta-ureidopropionase (ec 3.5.1.6) (beta-alanine synthase) (n-carbamoyl-beta-alanine amidohydrolase) (bup-1). [source:swissprot;acc:q9ubr1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3145\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1844\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3375.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3591.95\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06417\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1842\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bifunctional aminoacyl-trna synthetase [includes: glutamyl-trna synthetase (ec 6.1.1.17) (glutamate--trna ligase); prolyl-trna synthetase (ec 6.1.1.15) (proline--trna ligase)]. [source:swissprot;acc:p07814]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1209\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5420.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bifunctional purine biosynthesis protein purh [includes: phosphoribosylaminoimidazolecarboxamide formyltransferase (ec 2.1.2.3) (aicar transformylase); imp cyclohydrolase (ec 3.5.4.10) (inosinicase) (imp synthetase) (atic)]. [source:swissprot;acc:p31939]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2462\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5272.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5114.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [source:refseq;acc:nm\_001701]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1980\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6176.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
biotin--protein ligase (ec 6.3.4.-) (biotin apo-protein ligase) [includes: biotin--[methylmalonyl-coa-carboxyltransferase] ligase (ec 6.3.4.9); biotin--[propionyl-coa-carboxylase [atp-hydrolyzing]] ligase (ec 6.3.4.10) (holocarboxylase synthetase) (hcs); biotin--[methylcrotonoyl-coa-carboxylase] ligase (ec 6.3.4.11); biotin--[acetyl-coa-carboxylase] ligase (ec 6.3.4.15)]. [source:swissprot;acc:p50747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
846\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6194.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5607.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10478\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2260\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5387.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5150.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04615\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
470\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4348.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3796.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1455\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [source:swissprot;acc:p18577]\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
2270\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6869.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6568.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0459\vspace{3pt}}\\\cline{2-5}
&\parbox{\wcB}{\vspace{3pt}\noindent
2272\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6869.97\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6568.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04589\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
blood group rh(d) polypeptide (rhesus d antigen) (rhxiii) (rh polypeptide 2) (rhpii). [source:swissprot;acc:q02161]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2271\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
861\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6326.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5734.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2406\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bone morphogenetic protein 5 precursor (bmp-5). [source:swissprot;acc:p22003]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3069\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
bone morphogenetic protein 6 precursor (bmp-6). [source:swissprot;acc:p22004]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2896\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
bone morphogenetic protein 7 precursor (bmp-7) (osteogenic protein 1) (op-1). [source:swissprot;acc:p18075]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3128\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
bone morphogenetic protein 8 precursor (bmp-8) (osteogenic protein 2) (op-2). [source:swissprot;acc:p34820]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2773\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brachyury protein (t protein). [source:swissprot;acc:o15178]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6613.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6179.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1923\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6133.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5774.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brain protein 44. [source:swissprot;acc:o95563]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
328\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19007.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15999.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18801\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/